Association Between Fatty Liver and Cardiovascular Disease: Mechanism and Clinical Implications

QR Code

Association Between Fatty Liver and Cardiovascular Disease: Mechanism and Clinical Implications

None

Saved in:

Bibliographic Details
Main Authors:	W., Nseir, N., Assy
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/19487
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dehydroepiandrosterone in Nonalcoholic Fatty Liver Disease
by: Sumida, Yoshio, et al.
Published: (2012)

Liver Biopsy in Transplantation: Nonalcoholic Fatty Liver Disease and the Eosinophils
by: Sugawara, Yasuhiko, et al.
Published: (2011)

Transient Elastography for Assessment of Non-Alcoholic Fatty Liver Disease
by: Abenavoli, Ludovico
Published: (2011)

Histopathological Diagnosis of Non-Alcoholic and Alcoholic Fatty Liver Disease
by: Tannapfel, Andrea, et al.
Published: (2011)

Non-Alcoholic Fatty Liver Disease (NAFLD), Adipocytokines and Diabetes Mellitus
by: Sheriff, Dhastagir Sultan
Published: (2011)

Cholesterol and Inflammation at the Crossroads of Non-Alcoholic Fatty Liver Disease (NAFLD) and Atherogenesis
by: Lorbek, Gregor, et al.
Published: (2012)

Association Between Haemoglobin Variability and Clinical Outcomes in Chronic Kidney Disease
by: Malasingam, Roshini, et al.
Published: (2012)

The correlation between vitamin D level and liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Huajuan WANG, et al.
Published: (2025-06-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)

Cardiovascular Risk Factors: Implications in Diabetes, Other Disease States and Herbal Drugs
by: Ogbonnia, Steve
Published: (2012)

The association between serum pinenes and non-alcoholic fatty liver disease based on the NHANES 2013–2014
by: Tuo Xiao, et al.
Published: (2025-09-01)

The effect of non-alcoholic fatty liver disease on the development of cardiovascular diseases
by: N. A. Starodubtseva, et al.
Published: (2025-03-01)

Metabolomics in Cardiovascular Disease: Towards Clinical Application
by: Barba, Ignasi, et al.
Published: (2012)

Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications
by: Yuqing Niu, et al.
Published: (2025-08-01)

NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR COMPLICATIONS -WHAT IS THE RELATIONSHIP?
by: V. A. Azizov, et al.
Published: (2013-03-01)

Metabolically associated fatty liver disease. What is the danger of a "safe" disease? Pathogenesis of cardiovascular complications
by: M. A. Isaikina, et al.
Published: (2025-02-01)

Gender-Specific Aspects in the Clinical Presentation of Cardiovascular Disease
by: Leuzzi, Chiara, et al.
Published: (2012)

Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease
by: Huri, Hasniza Zaman
Published: (2012)

The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease
by: So-hyeon Hong, et al.
Published: (2025-08-01)

Relationship Between Cardiovascular Risk Factors and Periodontal Disease: Current Knowledge
by: Granados-Principal, Sergio, et al.
Published: (2012)

Cardiovascular Pathophysiology Produced by Natural Toxins and Their Possible Therapeutic Implications
by: Frangež, Robert, et al.
Published: (2012)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

Association of Cardiovascular Disease with the Metabolic Syndrome in a Predominantly Male Cohort with Rheumatoid Arthritis
by: Kerr, G.S., et al.
Published: (2012)

Alcoholism and Inflammatory Response: Implications for Liver and Cardiovascular Disease
by: Christian Gabriel Acosta Ricachi, et al.
Published: (2024-08-01)

Role of Fatty Acids in the Resolution of Autoimmune and Inflammatory Diseases
by: Puertollano, Elena, et al.
Published: (2011)

Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
by: A. V. Nelidova, et al.
Published: (2022-01-01)

Osteoimmunology and Cancer - Clinical Implications
by: Terpos, Evangelos, et al.
Published: (2011)

Cardiovascular Monitoring and Substitution of the Blood Volume During Liver Transplantation
by: Nissen, Peter, et al.
Published: (2012)

French Paradox, Polyphenols and Cardiovascular Protection: The Oestrogenic Receptor-α Implication
by: Benaissa, Tassadit, et al.
Published: (2012)

Dyslipidemia and Cardiovascular Disease
by: Fakhrzadeh, Hossein, et al.
Published: (2012)

Risk factors for cardiovascular disease in patients with non-alcoholic fatty liver disease with polymorbidity
by: E. V. Sevostyanova, et al.
Published: (2019-11-01)

Association Between Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Disease: Epidemiological Cross-Sectional Study and Mendelian Randomization Analysis
by: Yu T, et al.
Published: (2025-06-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE
by: O. M. Drapkina, et al.
Published: (2017-11-01)

Immunological Analysis of Liver Diseases with Liver Biopsy Specimens
by: Tajiri, Kazuto, et al.
Published: (2011)

The Relationship Between Gait Mechanics and Radiographic Disease Severity in Knee Osteoarthritis
by: Sims, Ershela L., et al.
Published: (2012)

Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
by: O. M. Drapkina, et al.
Published: (2016-09-01)

Cardiovascular Diseases in Kidney Transplantation
by: Marcén, Roberto, et al.
Published: (2011)

Gene Therapy in Cardiovascular Disease
by: Reyes-Juárez, José Luis, et al.
Published: (2011)

Cardiovascular Disease Risk Factors
by: Amani, Reza, et al.
Published: (2012)

Future of Pharmacogenetics in Cardiovascular Diseases
by: Schie, Rianne M.F. Van, et al.
Published: (2012)